Nā mea hana a me nā mea hoʻolako - hale hana huahana Kina

(1S,2S)-(+)-2-Amino-1-(4-nitrophenyl)-1,3-propanediol CAS 2964-48-9 Maʻemaʻe ≥99.0% Maʻemaʻe Kiʻekiʻe

Inoa: (1S,2S)-(+)-2-Amino-1-(4-nitrophenyl)-1,3-propanediol

L-(+)-threo-2-Amino-1-(4-nitrophenyl)-1,3-propanediol

CAS: 2964-48-9

'Ano: Keokeo a Pale Melemele Pada

Maʻemaʻe: ≥99.0% (HPLC)

Nā Hui Chiral, Hoʻokumu Kalepa

E-mail: alvin@ruifuchem.com

ninau kikoʻī
(1R,2R)-(-)-2-Amino-1-(4-nitrophenyl)-1,3-propanediol CAS 716-61-0 Maʻemaʻe ≥99.0% (HPLC) Maʻemaʻe Kiʻekiʻe

Inoa: (1R,2R)-(-)-2-Amino-1-(4-nitrophenyl)-1,3-propanediol

D-(-)-threo-2-Amino-1-(4-nitrophenyl)-1,3-propanediol

CAS: 716-61-0

'Ano: Keokeo a Pale Melemele Pada

Maʻemaʻe: ≥99.0% (HPLC)

Nā Hui Chiral, Hoʻokumu Kalepa

E-mail: alvin@ruifuchem.com

ninau kikoʻī
(S)-BoroLeu-(-)-Pinanediol-CF3COOH CAS 477254-69-6 Maʻemaʻe ≥97.0% Bortezomib haumia 37 Trifluoroacetate Maʻemaʻe Kiʻekiʻe

Inoa Kemika: (S)-BoroLeu-(-)-Pinanediol-CF3COOH

Synonyms: Bortezomib Impurity 37 Trifluoroacetate

CAS: 477254-69-6

ʻAno: Keʻokeʻo a i ʻole-White Crystalline Powder

Maʻemaʻe: ≥97.0%

ʻO ke kūlana kiʻekiʻe, ka hana kālepa

E-mail: alvin@ruifuchem.com

ninau kikoʻī
(1R,2R,3S,5R)-(-)-2,3-Pinanediol CAS 22422-34-0 ee ≥99.0% Maʻemaʻe ≥99.0% Hale Hana Maʻemaʻe Kiʻekiʻe

Inoa Kemika: (1R,2R,3S,5R)-(-)-2,3-Pinanediol

CAS: 22422-34-0

ʻAno: Keʻokeʻo a i ʻole-White Crystallized Powder

ee: ≥99.0%

Maʻemaʻe: ≥99.0% (GC)

Nā Hui Chiral, Hoʻokumu Kalepa

E-mail: alvin@ruifuchem.com

ninau kikoʻī
Bortezomib CAS 179324-69-7 Maʻemaʻe ≥99.0% (HPLC) API Hale Hana Maʻemaʻe Kiʻekiʻe

Inoa Kemika: Bortezomib

CAS: 179324-69-7

ʻAno: Pahu keʻokeʻo a i ʻole keʻokeʻo

Maʻemaʻe: ≥99.0% (HPLC)

ʻO Bortezomib i ka mālama ʻana i ka Multiple Myeloma

API Kūlana Kiʻekiʻe, Hana Hana Kūʻai

E-mail: alvin@ruifuchem.com

ninau kikoʻī
(1S,2S,3R,5S)-(+)-2,3-Pinanediol CAS 18680-27-8 ee ≥99.0% Maʻemaʻe ≥99.0% Bortezomib Intermediate High Maʻemaʻe

Inoa Kemika: (1S,2S,3R,5S)-(+)-2,3-Pinanediol

CAS: 18680-27-8

ʻAno: Keʻokeʻo a i ʻole-White Crystallized Powder

ee: ≥99.0%Maʻemaʻe: ≥99.0% (GC)

ʻO Intermediate o Bortezomib (CAS 179324-69-7) i ka mālama ʻana i ka Myeloma Nui.

Nā Hui Chiral, Hoʻokumu Kalepa

E-mail: alvin@ruifuchem.com

ninau kikoʻī
(1S,2S)-trans-1,2-Cyclohexanediol CAS 57794-08-8 Maʻemaʻe ≥98.5% Maʻemaʻe Kiʻekiʻe

Inoa Kemika: (1S,2S)-trans-1,2-Cyclohexanediol

Synonyms: (1S,2S)-Cyclohexane-1,2-diol

CAS: 57794-08-8

ʻAno: ʻO ka pauka kristal keʻokeʻo a me / a i ʻole nā ʻāpana

Maʻemaʻe: ≥98.5% (GC Area%)

Nā Hui Chiral, Hoʻokumu Kalepa

E-mail: alvin@ruifuchem.com

ninau kikoʻī
(1R,2R)-trans-1,2-Cyclohexanediol CAS 1072-86-2 Maʻemaʻe ≥98.5% Maʻemaʻe Kiʻekiʻe

Inoa Kemika: (1R,2R)-trans-1,2-Cyclohexanediol

Synonyms: (1R,2R)-Cyclohexane-1,2-diol

CAS: 1072-86-2

ʻAno: ʻO ka pauka kristal keʻokeʻo a me / a i ʻole nā ʻāpana

Maʻemaʻe: ≥98.5% (GC Area%)

Nā Hui Chiral, Hoʻokumu Kalepa

E-mail: alvin@ruifuchem.com

ninau kikoʻī
Lurasidone Hydrochloride CAS 367514-88-3 Maʻemaʻe ≥99.0% API Factory Maʻemaʻe Kiʻekiʻe

Inoa Kemika: Lurasidone Hydrochloride

Synonyms: Lurasidone HCl;Latuda

CAS: 367514-88-3

ʻAno: Keʻokeʻo a i ʻole Keʻokeʻo Crystalline Powder

Maʻemaʻe: ≥99.0%

ʻO kahi antipsychotic i hoʻohana ʻia no ka mālama ʻana i ka schizophrenia.

API Kūlana Kiʻekiʻe, Hana Hana Kūʻai

E-mail: alvin@ruifuchem.com

ninau kikoʻī
Lurasidon Hydrochloride Intermediate CAS 14805-29-9 Maʻemaʻe ≥99.0% (HPLC) Hale Hana Maʻemaʻe Kiʻekiʻe

Inoa Kemika: (3aR,4S,7R,7aS)-rel-Hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione

Synonyms: exo-2,3-Norbornanedicarboximide

CAS: 14805-29-9

'Ano: Keokeo a aneane keokeo ka pauda

Maʻemaʻe: ≥99.0% (HPLC)

Intermediate o Lurasidon Hydrochloride (CAS 367514-88-3), he antipsychotic i hoʻohana ʻia no ka mālama ʻana i ka schizophrenia.

ʻO ke kūlana kiʻekiʻe, ka hana kālepa

E-mail: alvin@ruifuchem.com

ninau kikoʻī
(1S,2S)-1,2-Cyclohexanedimethanol CAS 3205-34-3 Maʻemaʻe ≥98.0% (GC) Maʻemaʻe Kiʻekiʻe

Inoa Kemika: (1S,2S)-1,2-Cyclohexanedimethanol

CAS: 3205-34-3

ʻAno: Keʻokeʻo a i ʻole ka pauka keʻokeʻo

Maʻemaʻe: ≥98.0% (GC)

Nā Hui Chiral, Hoʻokumu Kalepa

E-mail: alvin@ruifuchem.com

ninau kikoʻī
(1R,2R)-1,2-Cyclohexanedimethanol CAS 65376-05-8 Maʻemaʻe ≥98.0% (GC) Lurasidon Hydrochloride Intermediate Maʻemaʻe Kiʻekiʻe

Inoa Kemika: (1R,2R)-1,2-Cyclohexanedimethanol

CAS: 65376-05-8

ʻAno: Keʻokeʻo a i ʻole ka pauka keʻokeʻo

Maʻemaʻe: ≥98.0% (GC)

Nā Hui Chiral, Hoʻokumu Kalepa

ʻO Intermediate o Lurasidon Hydrochloride (CAS 367514-88-3) i ka mālama ʻana i ka Schizophrenia

E-mail: alvin@ruifuchem.com

ninau kikoʻī
(1S,2S)-(-)-1,2-Diphenylethylenediamine CAS 29841-69-8 Maʻemaʻe ≥99.0% Maʻemaʻe Optical ≥99.0% Maʻemaʻe Kiʻekiʻe

Inoa: (1S,2S)-(-)-1,2-Diphenylethylenediamine

Nā huaʻōlelo like: (S,S)-DPEN

CAS: 29841-69-8

ʻAno: Keʻokeʻo a i ʻole Melemele Crystalline

Maʻemaʻe: ≥99.0%

Maʻemaʻe Optical: ≥99.0%

Nā Hui Chiral, Hoʻokumu Kalepa

E-mail: alvin@ruifuchem.com

ninau kikoʻī
(1R,2R)-(+)-1,2-Diphenylethylenediamine CAS 35132-20-8 Maʻemaʻe ≥99 .0% Maʻemaʻe Optical ≥99.0% Maʻemaʻe Kiʻekiʻe

Inoa: (1R,2R)-(+)-1,2-Diphenylethylenediamine

Nā huaʻōlelo like: (R,R)-DPEN

CAS: 35132-20-8

ʻAno: Keʻokeʻo a i ʻole ʻeleʻele melemele a i ʻole ka pauka

Maʻemaʻe: ≥99.0%

Maʻemaʻe Optical: ≥99.0%

Nā Hui Chiral, Hoʻokumu Kalepa

E-mail: alvin@ruifuchem.com

ninau kikoʻī

<< < Mamua 310 311 312 313 314 315 316 Aʻe >>> ʻAoʻao 313 / 341

Nā huahana

Tetrabutylammonium Fluoride Trihydrate CAS 87749-50-6 Maʻemaʻe >99.0% (Titration)

Tetrabutylammonium Bromide (TBAB) CAS 1643-19-2 Maʻemaʻe >99.0% ((Titration)

Ammonium Bromide CAS 12124-97-9 Maʻemaʻe >99.0% (Titration)

Tetra-n-Octylammonium Bromide (TOAB) CAS 14866-33-2 Maʻemaʻe >98.0% (Titration)

Didodecyldimethylammonium Bromide CAS 3282-73-3 Maʻemaʻe >99.0% (GC)

(S)-(-)-TolBINAP CAS 100165-88-6 Maʻemaʻe >98.0% (HPLC)

Dibromobis(triphenylphosphine)nickel(II) CAS 14126-37-5 Maʻemaʻe >99.0% (GC)

tert-Amyl Alcohol CAS 75-85-4 Maʻemaʻe >99.5% (GC)

tert-Butyl Hydroperoxide (TBHP) (70% i ka wai) CAS 75-91-2

Sodium tert-Butoxide CAS 865-48-5 Maʻemaʻe >99.0% (T)

Lithium tert-Butoxide CAS 1907-33-1 Maʻemaʻe >99.0% (Titration)

Trimethyltetradecylammonium Chloride CAS 4574-04-3 Maʻemaʻe >99.0% (T)

Tributyltin Hydride CAS 688-73-3 Maʻemaʻe >97.0% (GC) Loaʻa iā 0.05% BHT ma ke ʻano he Stabilizer

(1S,2S)-(+)-2-Amino-1-(4-nitrophenyl)-1,3-propanediol CAS 2964-48-9 Maʻemaʻe ≥99.0% Maʻemaʻe Kiʻekiʻe

(1R,2R)-(-)-2-Amino-1-(4-nitrophenyl)-1,3-propanediol CAS 716-61-0 Maʻemaʻe ≥99.0% (HPLC) Maʻemaʻe Kiʻekiʻe

(S)-BoroLeu-(-)-Pinanediol-CF3COOH CAS 477254-69-6 Maʻemaʻe ≥97.0% Bortezomib haumia 37 Trifluoroacetate Maʻemaʻe Kiʻekiʻe

(1R,2R,3S,5R)-(-)-2,3-Pinanediol CAS 22422-34-0 ee ≥99.0% Maʻemaʻe ≥99.0% Hale Hana Maʻemaʻe Kiʻekiʻe

Bortezomib CAS 179324-69-7 Maʻemaʻe ≥99.0% (HPLC) API Hale Hana Maʻemaʻe Kiʻekiʻe

(1S,2S,3R,5S)-(+)-2,3-Pinanediol CAS 18680-27-8 ee ≥99.0% Maʻemaʻe ≥99.0% Bortezomib Intermediate High Maʻemaʻe

(1S,2S)-trans-1,2-Cyclohexanediol CAS 57794-08-8 Maʻemaʻe ≥98.5% Maʻemaʻe Kiʻekiʻe

(1R,2R)-trans-1,2-Cyclohexanediol CAS 1072-86-2 Maʻemaʻe ≥98.5% Maʻemaʻe Kiʻekiʻe

Lurasidone Hydrochloride CAS 367514-88-3 Maʻemaʻe ≥99.0% API Factory Maʻemaʻe Kiʻekiʻe

Lurasidon Hydrochloride Intermediate CAS 14805-29-9 Maʻemaʻe ≥99.0% (HPLC) Hale Hana Maʻemaʻe Kiʻekiʻe

(1S,2S)-1,2-Cyclohexanedimethanol CAS 3205-34-3 Maʻemaʻe ≥98.0% (GC) Maʻemaʻe Kiʻekiʻe

(1R,2R)-1,2-Cyclohexanedimethanol CAS 65376-05-8 Maʻemaʻe ≥98.0% (GC) Lurasidon Hydrochloride Intermediate Maʻemaʻe Kiʻekiʻe

(1S,2S)-(-)-1,2-Diphenylethylenediamine CAS 29841-69-8 Maʻemaʻe ≥99.0% Maʻemaʻe Optical ≥99.0% Maʻemaʻe Kiʻekiʻe

(1R,2R)-(+)-1,2-Diphenylethylenediamine CAS 35132-20-8 Maʻemaʻe ≥99 .0% Maʻemaʻe Optical ≥99.0% Maʻemaʻe Kiʻekiʻe